Jaeggi E, Fouron J C, Drblik S P
Division of Pediatric Cardiology, Sainte-Justine Hospital, University of Montreal School of Medicine, Quebec, Canada.
J Pediatr. 1998 Feb;132(2):335-9. doi: 10.1016/s0022-3476(98)70455-x.
To assess clinical features, treatment efficacy, and outcome of fetal atrial flutter.
All atrial flutter cases seen in our unit between 1988 and 1995 were reviewed retrospectively and compared with the pooled data of 37 echocardiographically documented and published cases.
Atrial flutter was found in 15 of 49 (30.6%) fetuses who had been referred because of clinically relevant tachyarrhythmia. Mean age at detection was 34+/-4 weeks' gestation. Atrial flutter was incessant in 11 and intermittent in 4, with a mean atrial rate of 442+/-65 beats/min and a mean ventricular rate of 216+/-28 beats/min. A predominance of 2:1 atrioventricular conduction was observed. In 5 of 15 cases another form of arrhythmia (supraventricular tachycardia, chaotic atrial rhythm, ventricular extrasystoles) coexisted with atrial flutter. Eleven fetuses were treated with maternal digoxin, and five subsequently converted to sinus rhythm. Four fetuses received no medication; of these four, two showed brief self-limited episodes of atrial flutter and two were delivered after detection of the arrhythmia. Only one fetus (6.7%), who did not respond to drug therapy, was delivered prematurely because of mild congestive heart failure. Seven neonates were in atrial flutter at birth; rhythm control could be easily achieved with sotalol or digoxin (n = 5), flecainide (n = 1), or electroconversion (n = 1) within the first 2 days of life without any relapse.
Fetal atrial flutter accounts for approximately one third of all clinically relevant tachyarrhythmia. Although the suppression rate of incessant atrial flutter with digoxin is only 50%, this therapy may be useful for its positive inotropic and negative chronotropic properties. In our experience most fetuses with therapy-resistant atrial flutter and absence of 1:1 atrioventricular conduction do not experience congestive heart failure and do not need to be delivered prematurely. After birth, conversion to sinus rhythm was easily achieved in all neonates.
评估胎儿房扑的临床特征、治疗效果及预后。
回顾性分析1988年至1995年间在我院诊治的所有房扑病例,并与37例经超声心动图证实并发表的病例汇总数据进行比较。
在因临床相关快速心律失常转诊的49例胎儿中,发现15例(30.6%)为房扑。确诊时的平均孕周为34±4周。11例为持续性房扑,4例为间歇性房扑,平均房率为442±65次/分,平均室率为216±28次/分。观察到以2:1房室传导为主。15例中有5例同时存在另一种心律失常形式(室上性心动过速、紊乱性房性心律、室性早搏)与房扑并存。11例胎儿接受了母体地高辛治疗,其中5例随后转为窦性心律。4例胎儿未接受药物治疗;这4例中,2例出现短暂的自限性房扑发作,2例在心律失常被发现后分娩。只有1例胎儿(6.7%)对药物治疗无反应,因轻度充血性心力衰竭而早产。7例新生儿出生时为房扑;在出生后的头2天内,使用索他洛尔或地高辛(n = 5)、氟卡尼(n = 1)或电复律(n = 1)可轻松实现节律控制,且无任何复发。
胎儿房扑约占所有临床相关快速心律失常的三分之一。尽管地高辛对持续性房扑的抑制率仅为50%,但该疗法因其正性肌力和负性变时特性可能有用。根据我们的经验,大多数对治疗耐药且不存在1:1房室传导的胎儿不会发生充血性心力衰竭,也无需早产。出生后,所有新生儿均能轻松转为窦性心律。